Even though there is no RCT available for the symptomatic treatment of dystonia in MSA, there is some evidence for a favorable effect of botulinum toxin type A injections in the treatment of dystonia in atypical Parkinsonian disorders [34]. The gene discussed is SGCG; the disease is parkinsonian disorder.